MiMedx Group, Inc (NASDAQ: MDXG), a pioneering player in the biotechnology sector, is capturing investor attention with its significant potential upside of 150.43%. With a robust presence in the healthcare..
U.S. Physical Therapy, Inc. (NYSE: USPH) is carving out a significant niche within the healthcare sector, specifically in the Medical Care Facilities industry. With a market capitalization of $1.14 billion,..
Dynavax Technologies Corporation (DVAX), a biopharmaceutical entity headquartered in Emeryville, California, is carving a significant niche within the healthcare sector. With a market capitalization of $1.82 billion, this company is..
With its focus on surgical solutions in the medical instruments and supplies industry, AtriCure, Inc. (ATRC) stands as a pivotal player in the healthcare sector, offering a range of innovative..
CG Oncology, Inc. (NASDAQ: CGON), a prominent player in the biotechnology industry, has captured investor attention with its pioneering work in oncolytic immunotherapy, specifically targeting bladder cancer. Headquartered in Irvine,..
Alphatec Holdings, Inc. (NASDAQ: ATEC) has emerged as a noteworthy player in the medical devices industry, particularly in the realm of spinal disorder treatments. Based in Carlsbad, California, this healthcare..
GoodRx Holdings, Inc. (NASDAQ: GDRX) is a standout player in the healthcare sector, specifically within the health information services industry. Known for its innovative approach to prescription drug price comparison,..
UFP Technologies, Inc. (NASDAQ: UFPT), a key player in the healthcare sector, specifically within the medical devices industry, is capturing investor attention with its robust growth prospects and significant upside..
Twist Bioscience Corporation (NASDAQ: TWST), a frontrunner in the synthetic DNA landscape, presents an intriguing opportunity for investors with a potential upside of 16.61%, as indicated by its average analyst..
Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM), a biopharmaceutical trailblazer in the healthcare sector, is capturing investor attention with its focus on rare and orphan diseases. With a market capitalization of $5.3..
Progyny, Inc. (PGNY), a prominent player in the healthcare sector specializing in fertility benefits management, has been capturing investor attention with its promising potential upside of 61.78%. As a company..
Structure Therapeutics Inc. (NASDAQ: GPCR) is attracting considerable attention in the biotechnology sector, primarily due to its promising pipeline focused on chronic diseases with unmet medical needs. As a clinical-stage..
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a prominent player in the biotechnology industry, is capturing investor attention with its promising portfolio in the healthcare sector. The San Diego-based company, with a..
Liquidia Corporation (NASDAQ: LQDA), a promising player in the biopharmaceutical sector, is capturing investor attention with its innovative approach to treating rare cardiopulmonary diseases. With a market capitalization of $3.1..
ARS Pharmaceuticals, Inc. (NASDAQ: SPRY), a notable player in the biotechnology sector, has been capturing investor interest with its innovative approach to treating severe allergic reactions. Headquartered in San Diego,..
Ocular Therapeutix, Inc. (NASDAQ: OCUL), a prominent player in the biotechnology sector, is drawing investor attention with an enticing potential upside of 251.35%. With its focus on innovative treatments for..
For investors seeking a foothold in the biotechnology sector, Celldex Therapeutics, Inc. (NASDAQ: CLDX) presents a compelling opportunity. With a market capitalization of $1.96 billion, Celldex is positioned at the..
Novavax, Inc. (NASDAQ: NVAX), a prominent player in the biotechnology sector, has recently captured investor attention with its substantial potential upside of 70.31%. As a company devoted to the discovery,..
In the ever-evolving landscape of biotechnology, Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) stands out as a promising player, particularly in the field of eye care. With a market capitalization of $2.85..
Janux Therapeutics, Inc. (NASDAQ: JANX), a trailblazing entity in the biotechnology sector, is capturing investor attention with its innovative approach to cancer treatment. Headquartered in San Diego, California, Janux focuses..
